What medicine can cure uterine cancer

What medicine can cure uterine cancer? This is a question that many patients are concerned about. In fact, there are many neoadjuvant chemotherapy drugs for uterine cancer to choose from. The choice should be based on the patient's financial situation and the tolerance of their liver and kidney function to the drugs, so as to achieve the effect of minimal side effects and maximum efficacy.

The use of medication should be based on comprehensive considerations such as the size of the patient's tumor and whether it has spread. It is recommended to actively treat the symptoms after diagnosis. In the early stages, surgery is the first choice, and anti-tumor treatment should be continued after surgery. Chemotherapy can be combined with anti-cancer Chinese medicine, combining Chinese and Western medicine to kill cancer cells, improve the patient's immunity, effectively control the disease, and prolong the patient's life. If the patient is in pain, he can take pure Chinese medicine to relieve the patient's pain.

Conservative treatment recommends taking anti-cancer Chinese medicine oral liquid for treatment. ① Use drugs to replace the nutrients specifically needed for cancer cell growth to "starve" cancer cells; ② Induce the body to secrete tumor necrosis factor, causing cancer cells to die on their own; ③ It has a highly selective cytotoxic effect on cancer cells, but is harmless to normal cells; ④ Improve the patient's immune function, enhance their own anti-cancer ability to prevent tumor recurrence and metastasis. ⑤ It can improve or eliminate symptoms, prolong long-term efficacy, have stable and lasting effects, improve quality of life, and prolong life.

Combination chemotherapy: Currently, combination chemotherapy is often used for advanced cancer, recurrent cancer, or when used in combination with surgery or radiotherapy, and it has better effects than single-drug chemotherapy. In combination therapy, it should be noted that the drugs in the combination therapy should be effective when used alone; drugs with different anti-tumor mechanisms should be selected; toxic effects should not be cumulative; the dose of each drug should be as close as possible to the commonly used effective dose; and there should be no reduction in efficacy or antagonism between the drugs in the combination therapy.